Imunon, Inc. — Director's Dealing 2024

Jun 14, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2024-06-12

Reporting Person: Lindborg Stacy (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-12	Stock Option (Right to Buy)	$1.22	A	112500	Acquired	2034-06-12	Common Stock (112500)	Direct

Footnotes

F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2: The options vest as follows 1/4 on the one year anniversary of the grant and 1/4 on the second, third and fourth year anniversary